Navigation Links
MicuRx Completes $25 Million Series B Financing
Date:8/22/2013

ical trials in China, through the joint venture Shanghai MengKe Pharmaceuticals with Shanghai Zhangjiang Biomedical Industry Venture Capital, we look forward to initiating development of MRX-I through a Phase 2 clinical trial at selected centers in the United States, to ensure successful development of this compound internationally. Importantly, BVCF will be an exceptional partner for MicuRx, with broad contacts internationally and extensive healthcare experience to guide our strategic development and commercialization plans."

MRX-I: A Potent and Safe Oxazolidinone Antibiotic
MRX-I is a next-generation oral oxazolidinone antibiotic for treating Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Phase I clinical results demonstrated that MRX-I is safe and well tolerated in human subjects, with no signs of myelosuppression, the major toxicity concern for most oxazolidinone agents, including linezolid. In preclinical studies, MRX-I cures in vivo infections due to Gram-positive bacteria including MRSA and VRE effectively. In addition, MRX-I exhibits two-fold improved activity against MRSA strains as compared to linezolid.

About BVCF
BVCF (http://bvcf.com/, formally known as BioVeda China) is the first and go-to private equity and growth capital investor specializing in China Life Sciences and Healthcare industry. Headquartered in Shanghai, BVCF's team includes partners with premier academic background and extensive operational experience. Investors include institutional limited partners and leading MNC pharmaceutical companies. BVCF focuses on investment in mid-market (US$ 50 – 100 million enterprise value) Life Science and Healthcare companies in China. The BVCF team takes an active app
'/>"/>

SOURCE MicuRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent
2. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
3. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
4. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobioticâ„¢ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
5. CryoLife Completes Acquisition of Hemosphere
6. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
7. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
8. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
9. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
10. Ablative Solutions Completes $5.3M Series A Financing
11. Quantum OPS Completes $1.05M In Series A Financing To Advance Surgical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The Competitive ... regulatory and marketplace changes. CI leaders who adjust will ... In a new Best Practices, LLC study CI ... actionable insights, including: - Use secondary research ... primary research - Internal staff who are ...
(Date:8/29/2014)... , Aug. 29, 2014  A Boston Scientific ... study on stent removability and preliminary long term ... published in the August issue of the peer-reviewed ... 1 is being conducted in 11 countries ... covered self-expanding metal stents (FCSEMS) after extended indwell ...
(Date:8/29/2014)... Calif. , Aug. 29, 2014 Thoratec ... in device-based mechanical circulatory support therapies to save, support ... participating in the 2014 Morgan Stanley Global Healthcare Conference ... Burbach , President and Chief Executive Officer, will provide ... Eastern Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... England and TOKYO, June 29 , ... Sosei Group Corporation ("Sosei"; TSE Mothers ... commencement of a Phase III,clinical study by Novartis, with NVA237, ... obstructive pulmonary disease,(COPD). NVA237 is a dry powder formulation for ...
... and New Genetic Mutations Acting Together-- , , ... autism inheritance puzzle are emerging in the latest study ... Hospital of Philadelphia, the University of Pennsylvania ... identified 27 different genetic regions where rare copy number ...
Cached Medicine Technology:Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4
(Date:8/29/2014)... 2014 Indosoft, Inc. , a ... the release of its most advanced contact center product, ... new features as well as updates to existing aspects ... Q-Suite functionality on the presentation side has received an ... the script builder. This WYSIWYG editor allows admins ...
(Date:8/29/2014)... AGH Healthy Happenings, a community education and outreach ... at Atlantic General Hospital, are now offering area residents ... no-cost blood pressure screenings at a local pharmacy, the ... sports tournaments. , In addition, the Maryland ... management and falls prevention workshops on various dates and ...
(Date:8/29/2014)... Everyone dreams about looking absolutely great, ... , According to the latest review published by Daily ... imagined with the right tips and recommendations. , ... an amazingly effective and fast method of looking perfectly. ... program is really efficient when it comes to the ...
(Date:8/29/2014)... August 29, 2014 Daily Gossip reveals in its ... created by a former cold sores patient who suffered from this ... Ellie Gadsby, who decided to share her tips and advices, but ... , The author of the Get Rid of Cold Sores Fast ... years, while in the least 4 years outbreaks have become more ...
(Date:8/29/2014)... Daily Gossip reveals in its Stop Sciatica ... method of naturally curing this disease. , The program ... permanent cure in only one week. This is described as ... make huge sacrifices. , Moreover, with this new method ... of sciatica in just 8 minutes. , Interested customers ...
Breaking Medicine News(10 mins):Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3Health News:Shapeshifter Yoga Review Reveals Kris Fondran's New Body Shaping and Fat Loss Program 2Health News:Get Rid of Cold Sores Fast Review Reveals Simple Way to Eliminate Cold Sores in 12 Hours 2Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2
... Inc. (Nasdaq:,CEPH) announced today that Frank Baldino, Jr., Ph.D., ... Conference being held at the Westin St.,Francis Hotel in ... hour,presentation on Tuesday, January 8, 2008 beginning at 2:00 ... Cast and Archived Replay, Members of the financial ...
... "Experimental evidence that selection favors character displacement in ... and Mark D. Rausher (Duke University) , How ... affect their evolution" While there is abundant evidence ... of floral traits, there is little direct evidence ...
... Performance Excellence, ANN ARBOR, Mich., Jan. 4 ... Inc. as a 2007 Quality,Leadership Award recipient., ... honor for,organizational performance excellence in the state. It ... of examiners who perform a comprehensive site,visit and ...
... Shows Only a Fraction of Eligible Women Can Access State,s ... Breast Cancer Deadlier for Minorities, Uninsured, NEW ... New York City Affiliate of Susan G. Komen for the ... the Ryan-NENA,Community Health Center to release a revealing report describing ...
... have the condition, experts say , , FRIDAY, Jan. 4 (HealthDay News) ... in the United States and now affects 46 million Americans, or ... new report finds. , That number is expected to rise even ... of American adults will suffer from some form of arthritic disease, ...
... awards in the 2007 Association TRENDS All-Media Contest, such ... Magazine as well as the category won by the ... at the Salute to Association Excellence event on February ... official publication of the Society for Biomolecular Sciences. In ...
Cached Medicine News:Health News:Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference 2Health News:January American Naturalist highlights 2Health News:January American Naturalist highlights 3Health News:January American Naturalist highlights 4Health News:January American Naturalist highlights 5Health News:January American Naturalist highlights 6Health News:January American Naturalist highlights 7Health News:January American Naturalist highlights 8Health News:January American Naturalist highlights 9Health News:January American Naturalist highlights 10Health News:January American Naturalist highlights 11Health News:January American Naturalist highlights 12Health News:January American Naturalist highlights 13Health News:Michigan Quality Council (MQC) Names Oakwood Healthcare Inc. 2007 State Quality Award Recipient 2Health News:Susan G. Komen for the Cure, Ryan Community Health Centers, Breast Cancer Survivors Call on New York State to Expand Breast Cancer Screening, Treatment Programs 2Health News:46 Million Americans Suffer From Arthritis 2Health News:46 Million Americans Suffer From Arthritis 3
... Soft, foam-lined FoamWrap ThumWrap Splints offer ... splints. Ideal to relieve mild pain or ... during activities. Choose either the rigid or ... right amount of support. Washable and breathable, ...
... to comfortably restrict motion of the wrist ... a neutral position. It is fabricated of ... characteristics offer durable performance and long lasting ... of the wrist, hand, and thumb without ...
... is a custom wrist orthotic designed to limit the ... patient's maximum range-of-motion. , ,Indications: , Wrist ... fibrocartilage complex , Coles fracture - distal ... Partial tendon rupture , ORIF - Open ...
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility...
Medicine Products: